NBHA reduces acrolein-induced changes in ARPE-19 cells: Possible involvement of TGFβ

Current Eye Research

Volumn 36, Issue 4, 2011, Pages 370-378

  Vidro Kotchan, Eileen ^a   Yendluri, Bharat Bhushan ^a   Le Thai, Terrie ^a   Tsin, Andrew ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Acrolein; Age related macular degeneration; Retinal pigment epithelium; TGF ; VEGF

Indexed keywords

ACROLEIN; HYDROXYLAMINE; N BENZYLHYDROXYLAMINE; PROTEIN INHIBITOR; SIS 3; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL LINE; CELL VIABILITY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ACROLEIN; CELL LINE; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROXYLAMINES; ISOQUINOLINES; PYRIDINES; PYRROLES; RETINAL PIGMENT EPITHELIUM; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952772714     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.549601     Document Type: Article

References (70)

1. Fine SL, Berger JW, Maguire MG, et al. Age-related macular degeneration. N Engl J Med. 2000;342:483-492. (Pubitemid 30100237)
2. Kuksa V, Imanishi Y, Batten M, et al. Retinoid cycle in the vertebrate retina: Experimental approaches and mechanisms of isomerization. Vision Res. 2003;43:2959-2981. (Pubitemid 37383728)
3. Luna JD, Chan CC, Derevjanik NL, et al. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: Comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta- mediated breakdown. J Neurosci Res. 1997;49:268-280. (Pubitemid 27344187)
4. Kevany BM, Palczewski K. Phagocytosis of retinal rod and cone photoreceptors. Physiology (Bethesda). 2010;25:8-15.
5. Kopitz J, Holz FG, Kaemmerer E, et al. Lipids and lipid peroxidation products in the pathogenesis of age-related macular degeneration. Biochimie. 2004;86:825-831. (Pubitemid 39602762)
6. Chen H, Liu B, Lukas TJ, et al. The aged retinal pigment epithelium/choroid: A potential substratum for the pathogenesis of age-related macular degeneration. PLoS One 2008;3:e2339.
7. Radu RA, Hu J, Yuan Q, et al. Complement System Dysregulation and Oxidative Stress in the abca4-/- Mice. In: ARVO, Ft. Lauderdale, FL, 2010.
8. Zhou J, Kim SR, Westlund BS, et al. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci. 2009;50:1392-1399.
9. Nagineni CN, Samuel W, Nagineni S, et al. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen-activated protein kinases. J Cell Physiol. 2003;197:453-462. (Pubitemid 37487044)
10. Muether PS, Hermann MM, Koch K, et al. Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in a loss of visual acuity. Graefes Arch Clin Exp Ophthalmol. 2010.
11. Frippiat C, Chen QM, Zdanov S, et al. Subcytotoxic H2O2 stress triggers a release of transforming growth factor-beta 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem. 2001;276:2531-2537.
12. Frippiat C, Dewelle J, Remacle J, et al. Signal transduction in H2O2-induced senescence-like phenotype in human diploid fibroblasts. Free Radic Biol Med. 2002;33:1334-1346. (Pubitemid 35284918)
13. Yu AL, Fuchshofer R, Kook D, et al. Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-beta release. Invest Ophthalmol Vis Sci. 2009;50:926-935.
14. Unda R, Vidro-Kotchan E. Unpublished results. 2003.
15. Vogt RR, Unda R, Yeh LC, et al. Bone morphogenetic protein-4 enhances vascular endothelial growth factor secretion by human retinal pigment epithelial cells. J Cell Biochem. 2006;98:1196-1202. (Pubitemid 44128359)
16. Bian ZM, Elner SG, Elner VM. Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res. 2007;84:812-822. (Pubitemid 46590123)
17. Khan JC, Thurlby DA, Shahid H, et al. Smoking and age related macular degeneration: The number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol. 2006;90:75-80. (Pubitemid 43029901)
18. Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration: A review of association. Eye. 2005;19:935-944. (Pubitemid 43114972)
19. Lykkesfeldt J, Christen S, Wallock LM, et al. Ascorbate is depleted by smoking and repleted by moderate supplementation: A study in male smokers and nonsmokers with matched dietary antioxidant intakes. Am J Clin Nutr. 2000;71:530-536. (Pubitemid 30061233)
20. O'Neill CA, Halliwell B, van der Vliet A, et al. Aldehyde-induced protein modifications in human plasma: Protection by glutathione and dihydrolipoic acid. J Lab Clin Med. 1994;124:359-370. (Pubitemid 2143363)
21. Cross CE, O'Neill CA, Reznick AZ, et al. Cigarette smoke oxidation of human plasma constituents. Ann N Y Acad Sci. 1993;686:72-89; discussion 89-90.
22. Bertram KM, Baglole CJ, Phipps RP, et al. Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: Implications for age-related macular degeneration. Am J Physiol Cell Physiol. 2009;297:C1200-C1210.
23. Nguyen E, Picklo MJ Sr. Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation. Biochim Biophys Acta. 2003;1637:107-112. (Pubitemid 36071603)
24. Pan J, Chung FL. Formation of cyclic deoxyguanosine adducts from omega-3 and omega-6 polyunsaturated fatty acids under oxidative conditions. Chem Res Toxicol. 2002;15:367-372. (Pubitemid 34241375)
25. Bazan NG. Survival signaling in retinal pigment epithelial cells in response to oxidative stress: Significance in retinal degenerations. Adv Exp Med Biol. 2006;572:531-540.
26. Sheu SJ, Liu NC, Chen JL. Resveratrol protects human retinal pigment epithelial cells from acrolein-induced damage. J Ocul Pharmacol Ther. 2010;26:231-236.
27. Voloboueva LA, Liu J, Suh JH, et al. (R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage. Invest Ophthalmol Vis Sci. 2005;46:4302-4310. (Pubitemid 44264636)
28. Jia L, Liu Z, Sun L, et al. Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: Protection by (R)-alpha-lipoic acid. Invest Ophthalmol Vis Sci. 2007;48:339-348. (Pubitemid 47251422)
29. Shen JK, Dong A, Hackett SF, et al. Oxidative damage in age-related macular degeneration. Histol Histopathol. 2007;22:1301-1308. (Pubitemid 47470323)
30. Zhou J, Cai B, Jang YP, et al. Mechanisms for the induction of HNE-, MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res. 2005;80:567-580. (Pubitemid 40387526)
31. Ayalasomayajula SP, Kompella UB. Induction of vascular endothelial growth factor by 4-hydroxynonenal and its prevention by glutathione precursors in retinal pigment epithelial cells. Eur J Pharmacol. 2002;449:213-220.
32. Leonarduzzi G, Scavazza A, Biasi F, et al. The lipid peroxidation end product 4-hydroxy-2,3-nonenal up-regulates transforming growth factor beta1 expression in the macrophage lineage: A link between oxidative injury and fibrosclerosis. FASEB J. 1997;11:851-857. (Pubitemid 27371894)
33. Burcham PC, Kaminskas LM, Fontaine FR, et al. Aldehyde-sequestering drugs: Tools for studying protein damage by lipid peroxidation products. Toxicology. 2002;181-182:229-236. (Pubitemid 36015704)
34. Wood PL, Khan MA, Kulow SR, et al. Neurotoxicity of reactive aldehydes: The concept of "aldehyde load" as demonstrated by neuroprotection with hydroxylamines. Brain Res. 2006;1095:190-199.
35. Yoshida M, Tomitori H, Machi Y, et al. Acrolein toxicity: Comparison with reactive oxygen species. Biochem Biophys Res Commun. 2009;378:313-318.
36. Jinnin M, Ihn H, Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006;69:597-607. (Pubitemid 43121957)
37. Lange C, Thiersch M, Samardzija M, et al. The differential role of Jak/STAT signaling in retinal degeneration. Adv Exp Med Biol. 2010;664:601-607.
38. Krejsgaard T, Vetter-Kauczok CS, Woetmann A, et al. Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma. Leukemia. 2006;20:1759-1766. (Pubitemid 44574987)
39. Bondi CD, Manickam N, Lee DY, et al. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol. 21:93-102.
40. Saika S, Kono-Saika S, Tanaka T, et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab Invest. 2004;84:1245-1258. (Pubitemid 40063691)
41. Pfeffer BA, Flanders KC, Guerin CJ, et al. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res. 1994;59:323-333. (Pubitemid 24326996)
42. Nagineni CN, Cherukuri KS, Kutty V, et al. Interferon-gamma differentially regulates TGF-beta1 and TGF-beta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway. J Cell Physiol. 2007;210:192-200. (Pubitemid 44904715)
43. Heimsath EG Jr, Unda R, Vidro E, et al. ARPE-19 cell growth and cell functions in euglycemic culture media. Curr Eye Res. 2006;31:1073-1080. (Pubitemid 46005574)
44. Batista CK, Brito GA, Souza ML, et al. A model of hemorrhagic cystitis induced with acrolein in mice. Braz J Med Biol Res. 2006;39:1475-1481. (Pubitemid 46357863)
45. Joshi-Barve S, Amancherla K, Patil M, et al. Acrolein, a ubiquitous pollutant and lipid hydroperoxide product, inhibits antiviral activity of interferon-alpha: Relevance to hepatitis C. Free Radic Biol Med. 2009;47:47-54.
46. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007;35:7497-7504.
47. Pan J, Keffer J, Emami A, et al. Acrolein-derived DNA adduct formation in human colon cancer cells: Its role in apoptosis induction by docosahexaenoic acid. Chem Res Toxicol. 2009;22:798-806.
48. Park YS, Taniguchi N. Acrolein induces inflammatory response underlying endothelial dysfunction: A risk factor for atherosclerosis. Ann N Y Acad Sci. 2008;1126:185-189. (Pubitemid 351589296)
49. Saiki R, Nishimura K, Ishii I, et al. Intense correlation between brain infarction and protein-conjugated acrolein. Stroke. 2009;40:3356-3361.
50. Sakata K, Kashiwagi K, Sharmin S, et al. Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun. 2003;305:143-149. (Pubitemid 36535419)
51. Tomitori H, Usui T, Saeki N, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke. 2005;36:2609-2613.
52. Williams TI, Lynn BC, Markesbery WR, et al. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging. 2006;27:1094-1099. (Pubitemid 43850642)
53. Woodruff TJ, Wells EM, Holt EW, et al. Estimating risk from ambient concentrations of acrolein across the United States. Environ Health Perspect. 2007;115:410-415. (Pubitemid 46554440)
54. Kapphahn RJ, Giwa BM, Berg KM, et al. Retinal proteins modified by 4-hydroxynonenal: Identification of molecular targets. Exp Eye Res. 2006;83:165-175. (Pubitemid 44208739)
55. Kaemmerer E, Schutt F, Krohne TU, et al. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci. 2007;48:1342-1347. (Pubitemid 351261433)
56. Schutt F, Bergmann M, Holz FG, et al. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2003;44:3663-3668. (Pubitemid 36909809)
57. Liu Z, Sun L, Zhu L, et al. Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem. 2007; 103:2690-2700.
58. Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004;242:91-101. (Pubitemid 38208289)
59. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 2000;55:15-35; discussion 35-36.
60. Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997;81:154-162. (Pubitemid 27092496)
61. Vidro EK, Gee S, Unda R, et al. Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr Eye Res. 2008;33:984-993.
62. Gong G, Qin Y, Huang W, et al. Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis. Chem Biol Interact. 2010;184:366-375.
63. Kwolek-Mirek M, Bednarska S, Bartosz G, et al. Acrolein toxicity involves oxidative stress caused by glutathione depletion in the yeast Saccharomyces cerevisiae. Cell Biol Toxicol. 2009;25:363-378.
64. Lee SC, Seong GJ, Kim SH, et al. Synthesized TGF-beta s in RPE regulates cellular proliferation. Korean J Ophthalmol. 1999;13:16-24.
65. Atamna H, Paler-Martinez A, Ames BN. N-t-butyl hydroxylamine, a hydrolysis product of alpha-phenyl-N-t-butyl nitrone, is more potent in delaying senescence in human lung fibroblasts. J Biol Chem. 2000;275:6741-6748. (Pubitemid 30146210)
66. Hipkiss AR. On the anti-aging activities of aminoguanidine and N-t-butylhydroxylamine. Mech Ageing Dev. 2001;122:169-171. (Pubitemid 32144826)
67. Lee JH, Kim IS, Park JW. The use of N-t-butyl hydroxylamine for radioprotection in cultured cells and mice. Carcinogenesis. 2004;25:1435-1442. (Pubitemid 39162709)
68. Stevens JF, Maier CS. Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res. 2008;52:7-25. (Pubitemid 351211799)
69. Carmella SG, Chen M, Zhang Y, et al. Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography- atmospheric pressure chemical ionization tandem mass spectrometry: Effects of cigarette smoking. Chem Res Toxicol. 2007;20:986-990. (Pubitemid 47204811)
70. Chu J, Zhou CC, Lu N, et al. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J (Engl). 2008;121:2525-2533.